Section 172 report, engagement with stakeholders, cross reference to other disclosures and to governance GlaxoSmithKline plc – Annual report – 31 December 2025 Industry: pharmaceuticals Corporate governance (extract) Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading...